3 results
Approved WMOCompleted
To investigate whether treatment with sulodexide can reverse postprandial dyslipidemia in patients with type 2 diabetes mellitus
Approved WMORecruiting
The primary objective of this trial in CIAS is to assess the efficacy in improving cognitive impairment using MCCB in patients with schizophrenia treated for 26 weeks with Iclepertin 10mg as compared with placebo.
Approved WMOPending
To assess the efficacy of treatment with sulodexide for chronic heart failure.